Area of research
Pathology and Forensic Medicine · Surgery
Research interest
Research focused on Oncology and Cancer, with related work in Ketamine, Overweight, GSK-3. Notable publications include 'Association of frequent amplification of chromosome 11q13 in esophageal squamous cell cancer with clinical benefit to immune check point blockade', 'The effects of GSK-3β blockade on ketamine self-administration and relapse to drug-seeking behavior in rats', and 'Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label,...'.
Safety and efficacy of QLS31905 in patients with advanced solid tumors: Updated data from phase 1 study.
Sex-Specific Differences in Related Indicators of Blood Pressure in School-Age Children With Overweight and Obesity: A Cross-Sectional Study
Association of frequent amplification of chromosome 11q13 in esophageal squamous cell cancer with clinical benefit to immune check point blockade.
Tumor mutational burden identifies chemorefractory gastric cancer with overall survival advantage after receiving toripalimab, a PD-1 antibody.
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study.
The effects of GSK-3β blockade on ketamine self-administration and relapse to drug-seeking behavior in rats